Novel insights into the regulatory role of N6-methyladenosine methylation modified autophagy in sepsis DOI Creative Commons

Cheng-Fei Bi,

Jia Liu, Xiao Hu

et al.

Aging, Journal Year: 2023, Volume and Issue: unknown

Published: Dec. 18, 2023

Sepsis is defined as a life-threatening organ dysfunction caused by dysregulated host response to infection. It characterized high morbidity and mortality one of the major diseases that seriously hang over global human health. Autophagy crucial regulator in complicated pathophysiological processes sepsis. The activation autophagy known be great significance for protecting sepsis induced dysfunction. Recent research has demonstrated N6-methyladenosine (m6A) methylation well-known post-transcriptional RNA modification controls epigenetic gene expression well number biological In addition, m6A affects stability, export, splicing translation transcripts involved autophagic process. Although it been suggested regulates metabolic more frequently seen progression pathogenesis, underlying molecular mechanisms m6A-modified have not thoroughly elucidated. present article fills this gap providing an review its potential role development novel therapeutics.

Language: Английский

Methyltransferase METTL3 regulates neuropathic pain through m6A methylation modification of SOCS1 DOI
Liping Wu, Ning Peng,

Yingye Liang

et al.

Neuropharmacology, Journal Year: 2024, Volume and Issue: 261, P. 110176 - 110176

Published: Sept. 30, 2024

Language: Английский

Citations

2

The role of N-methyladenosine modification in acute and chronic kidney diseases DOI Creative Commons

Saiqi Qi,

Jie Song, Linjun Chen

et al.

Molecular Medicine, Journal Year: 2023, Volume and Issue: 29(1)

Published: Dec. 8, 2023

Abstract N 6-methyladenosine (m6A) modification is a kind of RNA in which methylation occurs at the sixth position adenosine RNA, can occur various RNAs such as mRNAs, lncRNAs and miRNAs. This one most prominent frequent posttranscriptional modifications within organisms has been shown to function dynamically reversibly variety ways, including splicing, export, attenuation translation initiation efficiency regulate expression. There are three main enzymes associated with m6A modification: writers, readers erasers. Increasing evidence that onset development kidney disease. In this article, we address important physiological pathological roles diseases (uremia, ischemia–reperfusion injury, drug-induced diabetic nephropathy) its molecular mechanisms provide reference for diagnosis clinical management diseases.

Language: Английский

Citations

6

Lipoxin A4 suppresses neutrophil extracellular traps formation through the FPR2-dependent regulation of METTL3 in ischemic stroke DOI Creative Commons
Na Wei, Lu Tan, Jifeng Gu

et al.

Brain Research Bulletin, Journal Year: 2024, Volume and Issue: unknown, P. 111178 - 111178

Published: Dec. 1, 2024

Language: Английский

Citations

1

METTL3 Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Activating the MAPK Signaling Pathway DOI Creative Commons
Yang Gao, Min Wang, Renyi Qin

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: Jan. 10, 2024

Abstract Inflammatory responses, apoptosis, and oxidative stress, are key factors that contribute to hepatic ischemia/reperfusion (I/R) injury, which may lead the failure of liver surgeries, such as hepatectomy transplantation. The N6-methyladenosine (m6A) modification has been implicated in multiple biological processes, its specific role mechanism I/R injury require further investigation. This study focused on RNA methylase METTL3 ischemia-reperfusion injury. Dot blotting analysis was used profile m6A levels tissues at different reperfusion time points mouse models. Hepatocyte-specific knockdown (HKD) mice were determine function during I/R. sequencing western performed assess potential signaling pathways involved with deficiency METTL3. Finally, AAV8-TBG-METTL3 injected through tail vein elucidate We found expression upregulated livers led an exacerbated inflammatory response increased cell death I/R, whereas overexpression reduced extent Bioinformatic revealed MAPK pathway significantly enriched METTL3-deficient mice. protected from possibly by inhibiting phosphorylation JNK ERK, but not P38.

Language: Английский

Citations

0

The effect of METTL3 on MDM2 impairs cell cycle homeostasis in podocytes during diabetic kidney disease DOI Creative Commons
Han Wu,

Ziyang Yu,

Yi Yang

et al.

Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown

Published: April 17, 2024

Abstract N6-Methyladenosine (m6A) methylation is involved in various pathological processes. Our previous study found abnormal expression of the methyltransferases enzyme METTL3 aging kidney tissues, resulting renal fibrosis and aging. In this study, we aim to elucidate its regulatory mechanisms diabetic disease (DKD) by establishing a conditional knockout model. We observed elevated m6A levels mice with type I diabetes cultured mouse podocytes exposed advanced glycation end-products (AGEs), which could be attributed increased expression. Podocyte-specific knockdown significantly mitigated podocyte injury streptozotocin (STZ)-induced mice, leading reduced urine albuminuria pathology. Mechanistically, induced modification MDM2, triggering subsequent degradation an IGF2BP2 dependent manner. Consequently, regulation induces MDM2 expression, activates Notch signaling pathway, cell cycle re-entry under conditions, releases inflammatory factors, dedifferentiation podocytes. Thus, METTL3-mediated aberrant plays pivotal role conditions. Targeting via potentially effective strategy for DKD treatment.

Language: Английский

Citations

0

METTL3 Deficiency Aggravates Hepatic Ischemia/Reperfusion Injury in Mice by Activating the MAPK Signaling Pathway DOI Creative Commons
Yang Gao, Min Wang, Renyi Qin

et al.

International Journal of Medical Sciences, Journal Year: 2024, Volume and Issue: 21(6), P. 1037 - 1048

Published: Jan. 1, 2024

Background: Inflammatory responses, apoptosis, and oxidative stress, are key factors that contribute to hepatic ischemia/reperfusion (I/R) injury, which may lead the failure of liver surgeries, such as hepatectomy transplantation.The N6-methyladenosine (m 6 A) modification has been implicated in multiple biological processes, its specific role mechanism I/R injury require further investigation.Methods: Dot blotting analysis was used profile m A levels tissues at different reperfusion time points mouse models.Hepatocyte-specific METTL3 knockdown (HKD) mice were determine function during I/R.RNA sequencing western performed assess potential signaling pathways involved with deficiency METTL3.Finally, AAV8-TBG-METTL3 injected through tail vein elucidate injury.Results: The expression upregulated livers injury.METTL3 led an exacerbated inflammatory response increased cell death I/R, whereas overexpression reduced extent injury.Bioinformatic revealed MAPK pathway significantly enriched METTL3-deficient mice.METTL3 protected from possibly by inhibiting phosphorylation JNK ERK, but not P38.Conclusions: aggravates activating pathway.METTL3 be a therapeutic target injury.

Language: Английский

Citations

0

Investigation of METTL3 as an inhibitor of kanamycin-induced ototoxicity via stress granule formation DOI Creative Commons

Yan Wu,

Yuyu Huang, Luyao Wang

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Aug. 13, 2024

Background Methyltransferase-like 3 (METTL3), a component of the N6-methyladenosine (m6A) methyltransferase family, exhibits significant expression in HEI-OC1 cells and cochlear explants. Aminoglycoside antibiotics, known for their ototoxic potential, frequently induce irreversible auditory damage hair cells, predominantly through oxidative stress mechanisms. However, specific role METTL3 kanamycin-induced cell loss remains unclear. Objective This study aims to elucidate mechanisms by which contributes ototoxicity. Methods Results In vivo experiments demonstrated notable reduction within explants following kanamycin administration, concomitant with formation granules (SGs). Similarly, 24-hour treatment led decreased induced SG both neonatal explants, corroborating observations. Lentivirus-mediated transfection was employed overexpress knockdown cells. Knockdown resulted increased reactive oxygen species (ROS) levels apoptosis kanamycin, while concurrently reducing formation. Conversely, overexpression attenuated ROS generation, rates, promoted kanamycin. Therefore, METTL3-mediated presents promising target mitigating generation rate apoptosis. Conclusion finding indicates that holds potential impairments rates.

Language: Английский

Citations

0

RNA modification in normal hematopoiesis and hematologic malignancies DOI Creative Commons
Xi Chen,

Yixiao Yuan,

Fan Zhou

et al.

MedComm, Journal Year: 2024, Volume and Issue: 5(11)

Published: Oct. 23, 2024

Abstract N6‐methyladenosine (m6A) is the most abundant RNA modification in eukaryotic cells. Previous studies have shown that m6A plays a critical role under both normal physiological and pathological conditions. Hematopoiesis differentiation are highly regulated processes, recent on mRNA methylation revealed how this controls cell fate malignant hematopoietic states. However, despite these insights, comprehensive understanding of its complex roles between development diseases remains elusive. This review first provides an overview components biological functions regulators. Additionally, it highlights origin, process, characteristics, regulatory mechanisms stem cells, as well features, immune properties, self‐renewal pathways leukemia Last, article systematically reviews latest research advancements factors hematopoiesis related diseases. More importantly, explores targeting regulators various signaling could effectively intervene leukemia, providing new insights potential therapeutic targets. Targeting may hold promise for achieving more precise effective treatments.

Language: Английский

Citations

0

Methyltransferase-like 3 represents a prospective target for the diagnosis and treatment of kidney diseases DOI Creative Commons
Bin Song, Xiaolong Wu, Yan Zeng

et al.

Human Genomics, Journal Year: 2024, Volume and Issue: 18(1)

Published: Nov. 14, 2024

Kidney disease is marked by complex pathological mechanisms and significant therapeutic hurdles, resulting in high morbidity mortality rates globally. A deeper understanding of the fundamental processes involved can aid identifying novel targets improving treatment efficacy. Current comprehensive data analyses indicate involvement methyltransferase-like 3 (METTL3) its role RNA N6-methyladenosine methylation various renal pathologies, including acute kidney injury, fibrosis, chronic disease. However, there a paucity thorough reviews that clarify functional METTL3 evaluate importance enhancing outcomes. This review seeks to systematically examine roles, mechanisms, potential clinical applications diseases. The findings presented suggest implicated etiology exacerbation disorders, affecting their onset, progression, malignancy, responsiveness chemotherapeutic agents through regulation specific genetic pathways. In conclusion, this underscores detrimental correlation between diseases, highlighting promise targeting METTL3. Additionally, it offers critical insights for researchers concerning diagnosis, prognosis, strategies conditions.

Language: Английский

Citations

0

The role of m6A modification in cardiovascular disease: A systematic review and integrative analysis DOI

Xu-Man Feng,

Yu Zhang, Ning Chen

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 143, P. 113603 - 113603

Published: Nov. 15, 2024

Language: Английский

Citations

0